Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dapagliflozin on serum magnesium in HNF1ß patients with renal hypomagnesemia
2024-518855-43-00Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in hypomagnesaemia comparing dapagliflozin with placebo (2 arms). Primary endpoint: Change in serum magnesium. Started Nov 2024; status: completed.
02
Drugs
dapagliflozin
03
Conditions
hypomagnesaemia
Beyond the preview
Go deeper on 2024-518855-43-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518855-43-00.